Diabetes Market Research Reports & Industry Analysis
The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.
Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.
The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.
... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...
Apr, 2017 50 pages... , MSD pharmaceuticals, Novartis India, Novo Nordisk India, Pfizer India, Sanofi Aventis, Sun Pharmaceuticals, USV India. Market Segments 1. INDIAN DIABETES MARKET BY TYPE 2. INDIAN DIABETES MARKET BY DRUG CLASS 3. INDIAN DIABETES MARKET BY DEVICES OMR REPORT COVERS: Comprehensive research methodology of Global Indian Diabetes Market ...
May, 2017This study covers the world outlook for diabetic macular edema (DME) treatments across more than ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... (DME) treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
Apr, 2017 300 pagesThis study covers the world outlook for diabetic food across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetic food. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
Apr, 2017 292 pagesThis study covers the world outlook for diabetes therapeutics and diagnostics across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 296 pagesThis study covers the world outlook for diabetes monitoring, treatment, and drug delivery products across ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 310 pagesThis study covers the world outlook for diabetes drugs across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetes drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
Apr, 2017 292 pagesThis study covers the world outlook for diabetes diagnostics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 293 pagesThis study covers the world outlook for diabetes diagnosis, treatment, and drug delivery devices across ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 310 pagesThis study covers the world outlook for diabetes devices and drugs across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... and drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
Apr, 2017 293 pagesThis study covers the world outlook for diabetes devices across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... diabetes devices. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
Apr, 2017 293 pagesThis study covers the world outlook for diabetes care devices across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 293 pagesNext generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change ... is expected to maintain adherence to medication in diabetic patients and improve the quality of life of diabetic patients. The global next generation diabetes therapy and drug delivery market was ...
Apr, 2017 140 pages... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...
Mar, 2017 54 pagesOpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 SUMMARY GlobalData estimates sales of diabetic foot ulcer (DFU) and diabetic foot infection (DFI) drugs to be approximately $292.1M across the ... most lucrative within the DFU space? Key Findings Prevalence of diabetes and resulting DFUs, DFIs are increasing across the 7MM ...
Dec, 2016 166 pages... be seen during pregnancy. The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well ... are being profiled. The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure ...
Dec, 2016 107 pagesMarket Insight Global Diabetes Market is expected to grow at a CAGR of 8.1 percent for the forecasted period of 2015-2020. The market is segmented on the basis of type of diabetes, drugs class and diabetic ...
May, 2016 140 pagesPharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2025 SUMMARY The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being ... costly burden of diabetic complications through the use of combination therapies and novel branded drugs. We anticipate that the type 2 diabetes market will experience ...
Jun, 2016 476 pages2016 Global Diabetic Food Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetic Food industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetic Food industry; 3.) the North American Diabetic Food industry; 4.) the European Diabetic Food industry; 5.) market entry and investment feasibility; and ...
Aug, 2016 146 pages2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetes Management industry; 3.) the North American Diabetes Management industry; 4.) the European Diabetes Management industry; 5.) market entry and investment feasibility; and ...
Aug, 2016 146 pagesFrontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies Summary Diabetes is a common long-term condition that can ...
Jun, 2016 73 pages... clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial ...
May, 2016 309 pages... clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI ...
May, 2016 58 pages... delivery devices segment. The global diabetes devices market is expected to reach USD 35.4 billion in 2024. The monitoring and diagnostic devices segment captured the largest market share of the overall market in 2015 ...
May, 2016 81 pages... report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States ...
May, 2016 44 pagesIMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the ... , market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing ...
Feb, 2017 50 pagesIMARC’s new report “Spain Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the Spain diabetes market. The report provides both current and future trends in the ... planning to foray into the Spain diabetes market in any form. What we have achieved in this report: Comprehensive situation analysis of the Spain diabetes epidemiology and its dynamics ...
Feb, 2017 51 pagesIMARC’s new report “Germany Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the Germany diabetes market. The report provides both current and future trends in the ... planning to foray into the Germany diabetes market in any form. What we have achieved in this report: Comprehensive situation analysis of the Germany diabetes epidemiology and its dynamics ...
Feb, 2017 51 pagesPre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials ...
Apr, 2016 270 pages... used to treat type 2 diabetes. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Type 2 Diabetes Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape ...
Mar, 2016 122 pages... types of therapeutics under development for Type-1 diabetes (Juvenile Diabetes) Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Type-1 diabetes (Juvenile Diabetes) pipeline ...
Dec, 2015 639 pagesThis study covers the world outlook for diabetic retinopathy therapeutics across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 293 pagesThis study covers the world outlook for diabetes monitoring devices across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...
Apr, 2017 292 pages2015 Global Type 2 Diabetes Mellitus Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Type 2 Diabetes Mellitus Therapeutics industry ... : 1.) basic information; 2.) the Asia Type 2 Diabetes Mellitus Therapeutics industry; 3.) the North American Type 2 Diabetes Mellitus Therapeutics industry; 4.) the European Type 2 Diabetes Mellitus Therapeutics industry; 5.) market entry and ...
Dec, 2015 161 pages2015 Global Type 1 Diabetes Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Type 1 Diabetes Therapeutics industry, focusing on the ... with: 1.) basic information; 2.) the Asia Type 1 Diabetes Therapeutics industry; 3.) the North American Type 1 Diabetes Therapeutics industry; 4.) the European Type 1 Diabetes Therapeutics industry; 5.) market entry and investment feasibility ...
Dec, 2015 161 pages... . “India Diabetes Management Devices Market & Opportunities, 2020” elaborates the following aspects of diabetes management devices market in India: India Diabetes Management Devices Plastic Market Size, Share & Forecast Segmental Analysis – Diabetes Monitoring Devices and Diabetes Management Delivery Devices ...
Dec, 2015 89 pages... ’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both ... , market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing ...
Feb, 2017 49 pagesIMARC’s new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both ... , diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each ...
Mar, 2016 46 pages... markets have declined. IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Chinese diabetes market. The report provides both ...
Feb, 2017 51 pages... 's Medical Devices sector report, “Insulin Delivery - Pipeline Review, 2015' provides an overview of Insulin Delivery currently in pipeline stage. The report provides comprehensive information on the pipeline products with ...
May, 2015 196 pagesWhat environmental market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis of Market Barriers ...
Apr, 2015What market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis ...
Apr, 2015PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 SUMMARY Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the ... associated metabolic syndrome, treatment for brittle diabetes, and increased patient compliance. SCOPE Overview of type 1 diabetes, including epidemiology, etiology, pathophysiology, symptoms, diagnosis ...
Mar, 2015 289 pages... 's Eylea). Converting any clinical advantage to the commercial setting may prove challenging, however, ... injection for Eylea. To better ascertain the impact of the Protocol T study results on uptake of Eylea, ... treatment of DME? In the first-line setting, what level of overall switching (or alternative new start ...
Apr, 2015... Diabetes Insipidus. API intelligence over marketed drugs for Diabetes Insipidus and gaining primary intelligence over active ingredients manufacturers across the globe. Uncovering opportunities in the rapidly growing the US markets ...
Aug, 2016 60 pages... and value of these teams. FirstWord's latest Physician Views poll seeks to gain some insight into how endocrinologists value the role that medical affairs ... asking US and EU5-based physicians: How important they view medical affairs teams in enabling effective communication between physicians and pharmaceutical companies? Which activities ...
Dec, 2014... diabetes, family history of diabetes, ethnicity, poor nutrition during pregnancy, unhealthy diet, physical inactivity, and IGT. TechNavio's analysts forecast the Global Type 2 Diabetes Therapeutics market ... , Japan, India, Russia, and other APAC countries) TechNavio's report, Global Type 2 Diabetes Therapeutics Market 2015-2019, has been prepared based on an in-depth market ...
Dec, 2014 112 pagesEpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction of pancreatic ... programs. Scope The Type 1 Diabetes EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for type 1 diabetes in the eight ...
Nov, 2014 49 pages... growing segments included the continuous glucose monitoring (CGM), insulin pump and supplies, modern insulin, insulin pens and pen needle markets. These segments have one aspect in common: they are newer ways of treating diabetes. CGM and pump technologies are improving at a fast pace toward full integration ...
May, 2014 212 pagesThis market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fueled by an increasing number ...
Dec, 2012 229 pages